Cervical Cancer News and Research

RSS

Cancer is a disease in which cells in the body grow out of control. Cancer is always named for the part of the body where it starts, even if it spreads to other body parts later. When cancer starts in the cervix, it is called cervical cancer. The cervix is the lower, narrow end of the uterus. Also known as the womb, the uterus is where a baby grows when a woman is pregnant. The cervix connects the upper part of the uterus to the vagina (birth canal).

Cervical cancer is highly preventable in most Western countries because screening tests and a vaccine to prevent HPV infections are available. When cervical cancer is found early, it is highly treatable and associated with long survival and good quality of life.

Study improves understanding of early ovarian cancer

A new University of Michigan Medical School study sheds light on cell defects that lead to one common type of ovarian cancer and puts forth a promising new mouse model that already is being used for preclinical drug testing.

12 Apr 2007

New mouse model for ovarian cancer

12 Apr 2007

Roche and Transgene S.A. partner on HPV vaccine program

Roche and Transgene S.A. have announced that they have entered into an exclusive worldwide collaboration agreement to develop and commercialize products from Transgene's therapeutic vaccine program against Human Papilloma Virus-mediated diseases.

11 Apr 2007

HPV scientists to be honored

The potential for a new vaccine to eliminate cervical cancer caused by the human papillomavirus, or HPV, will be celebrated during the James P. Wilmot Cancer Center's eighth annual Discovery Ball on Saturday, April 28, at the Rochester Riverside Convention Center.

11 Apr 2007

Rising vaccine costs put kids at risk

The American Academy of Pediatrics (AAP) is alarmed that the soaring costs of vaccines combined with lower reimbursements from insurance companies will lead to the under- immunization of the nation's children and unnecessary outbreaks of preventable diseases.

11 Apr 2007

Giving stop smoking advice with smear tests could save extra lives

Giving women who smoke advice on quitting when they go for cervical smear tests could be an effective way of saving even more lives - according to new research published in the British Journal of Cancer. If introduced, the measure could benefit hundreds of thousands of women every year.

11 Apr 2007

Montefiore Medical Center launches human papilloma virus clinic

The only HPV (Human Papilloma Virus) Vaccine Clinic of its kind has been launched at Montefiore Medical Center.

7 Apr 2007

Bayh calls for tripling of breast cancer research funds

U.S. Senator Evan Bayh called for a dramatic increase in breast cancer research funding at a reception for recipients of the Marvella Bayh Memorial Scholarship at Indiana University's Cancer Research Institute on IUPUI's campus today.

5 Apr 2007

Reauthorization of the National Breast and Cervical Cancer Early Detection Program gives women access to life-saving early detection

For the past four years, Susan G. Komen for the Cure, the world's largest grassroots network of breast cancer survivors and activists have tirelessly advocated for reauthorization of the National Breast and Cervical Cancer Early Detection Program (NBCCEDP).

4 Apr 2007

Recognition for cancer researchers

World-class cancer researchers whose science has significantly contributed to progress in the fight against cancer will be recognized April 14-18, 2007, by the American Association for Cancer Research (AACR) at its 2007 Annual Meeting in Los Angeles, Calif.

3 Apr 2007

New York progresses HPV vaccine distribution to health providers, school clinics

The New York City Department of Health and Mental Hygiene on Thursday announced that it has distributed 57,810 doses of Merck's human papillomavirus vaccine Gardasil to city health providers, including school-based health clinics, the New York Post reports.

2 Apr 2007

New screening method for cervical cancer holds promise

A method of screening women in Ghana for early signs of cervical cancer and providing preventive treatment at the same visit appears to be safe, acceptable to women and feasible, according to a study by a researcher at the Stanford University School of Medicine.

2 Apr 2007

GlaxoSmithKline submits Biologics License Application (BLA) for CERVARIX

If licensed, the vaccine will be indicated for the prevention of cervical cancer and precancerous lesions associated with the most common cancer-causing human papillomavirus types.

1 Apr 2007

HPV vaccine proposals in Florida, Georgia, North Carolina, South Dakota

Merck's HPV vaccine Gardasil and GlaxoSmithKline's HPV vaccine Cervarix in clinical trials have been shown to be 100% effective in preventing infection with HPV strains 16 and 18, which together cause about 70% of cervical cancer cases.

22 Mar 2007

Canada budgets $258 million for human papillomavirus vaccination programs

The Canadian government on Monday announced that it is including about $258 million in the 2007-2008 budget to help pay for provincial human papillomavirus vaccination programs, Toronto's Globe and Mail reports.

22 Mar 2007

AACR's Sixth Annual Landon Awards recognize Richard Kolodner, Douglas Lowy and John Schiller

Scientists whose discoveries have led to fundamental advances in the science and treatment of cancer are the recipients of two prestigious international prizes offered by the Kirk A. and Dorothy P. Landon Foundation and the American Association for Cancer Research.

22 Mar 2007

Lack of preventive care, not HPV vaccine, 'real' reason 'too many women still die of cervical cancer'

The "real" reason that "[t]oo many women still die of cervical cancer" is the "lack of access to preventive medical care for low-income women and not the lack of a vaccine," Wall Street Journal columnist and Illinois-based physician Benjamin Brewer writes in an opinion piece.

11 Mar 2007

Gardasil not provided at most New York City health clinics

Merck's human papillomavirus vaccine Gardasil is not provided at most New York City health clinics, and girls and women who are eligible for no-cost or low-cost vaccination often are told they must pay for it, according to a report released on Wednesday by Public Advocate Betsy Gotbaum, the New York Sun reports.

11 Mar 2007

Two Roche HPV diagnostic tests to receive FDA review

Roche on Tuesday announced that FDA will review applications for the company's two human papillomavirus diagnostic tests, the Baltimore Sun reports

8 Mar 2007

Debate over HPV vaccine 'clouded' by worries about promiscuity

The debate over the Merck's human papillomavirus vaccine Gardasil has been "clouded" by "worries about promiscuity," New York Times reporter Denise Grady writes in a column

8 Mar 2007